ConductScience.org, home

Paper41301083

Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model.

Martin G and 9 others. Cancers (Basel), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model. Papers, record 41301083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301083

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-11-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martin GGrace
2Lee KYKa Ying
3Roberts CChristopher
4Zheng JJinxia
5Batth GKGagan Kaur
6Dalleywater WWilliam
7Khanim FLFarhat Latif
8Oltean SSebastianhttps://orcid.org/0000-0001-7890-8439
9Gaston KKevinhttps://orcid.org/0000-0002-7349-5513
10Jayaraman PSPadma-Sheelahttps://orcid.org/0000-0002-6500-9095

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/N012615/1UK Medical Research CouncilPubMed
2019/204AMMFPubMed

Source PubMed

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132416072Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.Lancet Oncol2020https://conductscience.org/library/papers/32416072PubMed
232606456Cholangiocarcinoma 2020: the next horizon in mechanisms and management.Nat Rev Gastroenterol Hepatol2020https://conductscience.org/library/papers/32606456PubMed
338357420Cholangiocarcinoma across England: Temporal changes in incidence, survival and routes to diagnosis by region and level of socioeconomic deprivation.JHEP Rep2024https://conductscience.org/library/papers/38357420PubMed
428877265Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line.PLoS One2017https://conductscience.org/library/papers/28877265PubMed
530258081Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers.Nat Commun2018https://conductscience.org/library/papers/30258081PubMed
631843982A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition.Cancer Res2020https://conductscience.org/library/papers/31843982PubMed
737917550Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.Cancer Biol Ther2023https://conductscience.org/library/papers/37917550PubMed
836765923CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges.Cancers (Basel)2023https://conductscience.org/library/papers/36765923PubMed
938838500An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.ESMO Open2024https://conductscience.org/library/papers/38838500PubMed
1019072826Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.Hepatology2009https://conductscience.org/library/papers/19072826PubMed
113196713Structural requirements of salicylanilides for uncoupling activity in mitochondria: quantitative analysis of structure-uncoupling relationships.Biochim Biophys Acta1988https://conductscience.org/library/papers/3196713PubMed
1234504109Cholangiocarcinoma.Nat Rev Dis Primers2021https://conductscience.org/library/papers/34504109PubMed
1336479072The magic bullet: Niclosamide.Front Oncol2022https://conductscience.org/library/papers/36479072PubMed
1422829072Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production.Blood Cancer J2011https://conductscience.org/library/papers/22829072PubMed
1517580084The homeobox gene Hhex is essential for proper hepatoblast differentiation and bile duct morphogenesis.Dev Biol2007https://conductscience.org/library/papers/17580084PubMed
1632223935TRK inhibitors in TRK fusion-positive cancers.Ann Oncol2019https://conductscience.org/library/papers/32223935PubMed
171360645Identification of a novel vertebrate homeobox gene expressed in haematopoietic cells.Nucleic Acids Res1992https://conductscience.org/library/papers/1360645PubMed
1832961231Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways.Life Sci2020https://conductscience.org/library/papers/32961231PubMed
1912826010The transcriptional repressor protein PRH interacts with the proteasome.Biochem J2003https://conductscience.org/library/papers/12826010PubMed
2038025687Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells.PeerJ2023https://conductscience.org/library/papers/38025687PubMed

See all 44 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HHEX3087PubTator's text mininghttps://conductscience.org/library/genes/3087

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301083

GET https://conductscience.org/api/papers/v1/41301083/references?page=2